Ginsenoside Rg2 Attenuated Trastuzumab-Induced Cardiotoxicity in Rats
Sign Up to like & getrecommendations! Published in 2022 at "BioMed Research International"
DOI: 10.1155/2022/8866660
Abstract: Aim Trastuzumab (TZM) is a monoclonal antibody drug for HER2-positive breast cancer by targeting epidermal growth factor 2, but it has significant cardiotoxicity. Ginsenoside Rg2 has shown a variety of biological activities. This study was… read more here.
Keywords: ginsenoside rg2; induced cardiotoxicity; cardiotoxicity; tzm induced ... See more keywords
Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0227961
Abstract: Purpose Trastuzumab (TZM) improves survival and the risk of recurrence among patients with early-stage HER2+ breast cancer (BC). TZM treatment can be given intravenously (IV-TZM) or subcutaneously (SC-TZM). Although both methods have similar efficacy and… read more here.
Keywords: administration; cost minimization; analysis; treatment ... See more keywords
Properties of Titanium Zirconium Molybdenum Alloy after Exposure to Indium at Elevated Temperatures
Sign Up to like & getrecommendations! Published in 2022 at "Materials"
DOI: 10.3390/ma15155270
Abstract: Titanium zirconium molybdenum (TZM) is a high strength at high temperature alloy with favorable properties for use in high temperature structural applications. Use of TZM in high pressure, gas-containing autoclave systems was recently demonstrated for… read more here.
Keywords: titanium zirconium; temperature; tzm; zirconium molybdenum ... See more keywords